Capital Flow Monitor · Sponsors · CIK 2087033
OrbiMed Private Investments X, LP
601 LEXINGTON AVENUE, NEW YORK, NY, 10022 · 212-739-6400
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
$1.75B
Sold
$1.67B
% sold
95.4%
Investors
119
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | D/A ·current | 506(b) | $1.75B | $1.67B | 95.4% | 119 | EDGAR ↗ |
| 2025-09-29 | D | 506(b) | $1.75B | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A OrbiMed Capital GP X, LP — Executive Officer, New York, NY
- N/A OrbiMed Capital GP X LLC — Executive Officer, New York, NY
- N/A OrbiMed Advisors LLC — Executive Officer, New York, NY
-
Mona Ashiya — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
David P. Bonita — Executive Officer, New York, NY
1 other raise
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
Sven H. Borho — Executive Officer, New York, NY
5 other raises
- OrbiMed Partners, Ltd. $2.61B of —
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Genesis Fund, Ltd. $145.9M of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
Carl L. Gordon — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
Geoffrey C. Hsu — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
W. Carter Neild — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Asia Partners VI, L.P. $534.0M of $850.0M · 62.8%
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
Matthew S. Rizzo — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
C. Scotland Stevens — Executive Officer, New York, NY
2 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
-
Peter A. Thompson — Executive Officer, New York, NY
3 other raises
- OrbiMed Partners II, L.P. $1.78B of —
- OrbiMed Genesis Fund, L.P. $353.3M of —
- RECODE THERAPEUTICS, INC. $29.4M of $29.4M · 100.0%
Placement agents
- Merrill Lynch, Pierce Fenner & Smith Incorporated · 21 RE raises
- Ubs Financial Services Inc. · 18 RE raises
- Ubs Switzerland Ag · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.